MLA Diagnostics
mladx.com
Actively hiring
Oncology Therapeutics
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
NLC Health Ventures, LIOF
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 15%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
NLC Health Ventures 
LIOF Similar startupsby what they do, their industry and backers
Learn about Lyell and how we are building an industry-leading clinical-stage pipeline of CAR-T cell product candidates for cancer.
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies…
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in…
What if we made as many cancer drugs next year as we have in the last decade?
Innovating life-changing medicines for cancer patients. At Kumquat, we're on a mission to transform cancer treatment by delivering durable…
Targeting the Tumor Ecosystem to address cancer drug resistance and improve patients’ lives.
Overview
Company Focus Accurate prognosis of early stage melanoma is limited in current care Cutaneous melanoma is the most deadly form of skin cancer with a rapidly increasing incidence rate. In 2018 there were 287,000 new cases and 60,000 deaths worldwide*.